Table of Contents
In terms of formulation market share gains, lyophilized injectable drugs are the fastest growing drug formulation segment. From 1990 to 1998 the share of newly approved lyophilized drugs as a share of all injectable/infusible drugs was 11.9%. In 2011, it was 41% and in 2013, injectable/infusible drugs requiring reconstitution made up half of all new approvals. Because a significant number of these drugs are developed for self-administration, they present special challenges for developers. Dual chamber syringes & injectors – designed to simplify reconstitution without patient handling of drug or diluent – have become the mainstay delivery option for this class of drugs. As lyophilized injectables continue to increase in number and market share, dual chamber syringes and injectors will experience double-digit annual unit growth.
What You Will Learn
-What are the currently marketed dual chamber syringes and injection devices and what is their impact on markets for therapeutic injectable lyophilized drugs?
-What are the therapeutic demand drivers for user-friendly point-of-use reconstitution devices and what specifically is the potential of dual chamber syringes and injector systems?
-What are the key dual chamber device selection factors, technologies and market development issues?
-What doses the current dual chamber device market look like, who are the market leaders, and what will this market look like in 2022?
-What companies supply dual chamber syringe and injector devices, and what are their product activities, business strategies, and corporate alliances and affiliations?
-How important are pharma-device alliances and design partnerships on dual chamber injection devices?
-What is the impact of economic, technology, and regulatory factors?
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
North America Facial Injectables Market: Overview This report on the North America facial injectables market analyzes the current and future prospects of the market. The report comprises an elaborate executive ...
Global Pulmonary Drug Delivery Devices Market: Overview This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report ...
The global injectable drug delivery market, in terms of value, is projected to reach USD 624.50 billion by 2021 from USD 362.38 billion in 2016, at a CAGR of 11.5% during the forecast period. The increase ...